Ranking and clustering of nodes in networks with smart teleportation

Random teleportation is a necessary evil for ranking and clustering directed networks based on random walks. Teleportation enables ergodic solutions, but the solutions must necessarily depend on the exact implementation and parametrization of the teleportation. For example, in the commonly used PageRank algorithm, the teleportation rate must trade off a heavily biased solution with a uniform solution. Here we show that teleportation to links rather than nodes enables a much smoother trade-off and effectively more robust results. We also show that, by not recording the teleportation steps of the random walker, we can further reduce the effect of teleportation with dramatic effects on clustering.Comment: 10 pages, 7 figure

Smart HBs in the design of crystals, molecular devices and functional materials

n/

Relationships between milk coagulation property traits analyzed with different methodologies.

Milk coagulation properties (MCP) analysis is performed using a wide range of methodologies in different countries and laboratories, using different instruments, coagulant activity in the milk, and type of coagulant. This makes it difficult to compare results and data from different research. The aims of this study were to propose a method for the transformation of values of rennet coagulation time (RCT) and curd firmness (a(30)) and to predict the noncoagulation (NC) probability of milk samples analyzed using different methodologies. Individual milk samples were collected during the morning milking in October 2010 from each of 165 Holstein-Friesian dairy cows in 2 freestall barns in Italy, and sent to 3 laboratories for MCP analysis. For each laboratory, MCP analysis was performed using a different methodology: A, with a computerized renneting meter instrument using 0.051 international milk clotting units (IMCU)/mL of coagulant activity; B, with a Lattodinamografo (Foss-Italia, Padova, Italy) using 0.051 IMCU/mL of coagulant activity; and C, with an Optigraph (Ysebaert, Frépillon, France) using 0.120 IMCU/mL of coagulant activity. The relationships between MCP traits were analyzed with correlation and regression analyses for each pair of methodologies. For each MCP trait, 2 regression models were applied: model 1 was a single regression model, where the dependent and independent variables were the same MCP trait determined by 2 different methodologies; in model 2, both a(30) and RCT were included as independent variables. The NC probabilities for laboratories with the highest number of NC samples were predicted based on the RCT and a(30) values measured in the laboratories with lower number of NC samples using logistic regression and receiver operating characteristic analysis. The percentages of NC samples were 4.2, 11.5, and 0.6% for A, B, and C, respectively. The transformation of MCP traits was more precise with model 1 for RCT (R(2): 0.77-0.82) than for a(30) (R(2): 0.28-0.63). The application of model 2 was needed when the C measurements were transformed into the other scales. The analyses of NC probabilities of milk samples showed that NC samples from one methodology were well distinguishable (with an accuracy of 0.972-0.996) based on the rennet coagulation time measured with the other methodology. A standard definition for MCP traits analysis is needed to enable reliable comparisons between MCP traits recorded in different laboratories and in different animal populations and breeds

Exploiting poly(I:C) to induce cancer cell apoptosis

TLR3 belong to the Toll-like receptors family, it is mainly expressed on immune cells where it senses pathogen-associated molecular patterns and initiates innate immune response. TLR3 agonist poly(I:C) was developed to mimic pathogens infection and boost immune system activation to promote anti-cancer therapy. Accordingly, TLR agonists were included in the National Cancer Institute list of immunotherapeutic agents with the highest potential to cure cancer. Besides well known effects on immune cells, poly(I:C) was also shown, in experimental models, to directly induce apoptosis in cancer cells expressing TLR3. This review presents the current knowledge on the mechanism of poly(I:C)-induced apoptosis in cancer cells. Experimental evidences on positive or negative regulators of TLR3-mediated apoptosis induced by poly(I:C) are reported and strategies are proposed to successfully promote this event in cancer cells. Cancer cells apoptosis is an additional arm offered by poly(I:C), besides activation of immune system, for the treatment of various type of cancer. A further dissection of TLR3 signaling would contribute to greater resolution of the critical steps that impede full exploitation of the poly(I:C)-induced apoptosis. Experimental evidences about negative regulator of poly(I:C)-induced apoptotic program should be considered in combinations with TLR3 agonists in clinical trials

Relationship between body composition, inflammation and lung function in overweight and obese asthma

Background: The obese-asthma phenotype is not well defined. The aim of this study was to examine both mechanical and inflammatory influences, by comparing lung function with body composition and airway inflammation in overweight and obese asthma. Methods: Overweight and obese (BMI 28-40 kg/m2) adults with asthma (n = 44) completed lung function assessment and underwent full-body dual energy x-ray absorptiometry. Venous blood samples and induced sputum were analysed for inflammatory markers. Results: In females, android and thoracic fat tissue and total body lean tissue were inversely correlated with expiratory reserve volume (ERV). Conversely in males, fat tissue was not correlated with lung function, however there was a positive association between android and thoracic lean tissue and ERV. Lower body (gynoid and leg) lean tissue was positively associated with sputum %neutrophils in females, while leptin was positively associated with android and thoracic fat tissue in males. Conclusions: This study suggests that both body composition and inflammation independently affect lung function, with distinct differences between males and females. Lean tissue exacerbates the obese-asthma phenotype in females and the mechanism responsible for this finding warrants further investigation

Crescimento e desenvolvimento de pessegueiros 'Chimarrita' e 'Maciel' sobre diferentes porta-enxertos e locais de cultivo.

Objetivou-se com o presente trabalho avaliar a influência dos porta-enxertos no que se refere ao crescimento vegetativo e desenvolvimento dos pessegueiro 'Chimarrita' e 'Maciel' em três locais de cultivo. O experimento foi desenvolvido em três locais de cultivo: 1 (Embrapa Uva e Vinho), 2 (EEA UFRGS) e 3 (CAP UFPel), em três anos. As cultivares de pessegueiro utilizadas foram: 'Chimarrita' e 'Maciel' enxertadas sobre seis porta-enxertos ('Aldrighi', 'Capdeboscq', 'Flordaguard', 'Nemaguard', 'Okinawa' e Umezeiro), no espaçamento 1,5 X 5,0m e conduzidas no sistema em ?V?. Foram avaliados: volume de copa, diâmetro de tronco, massa fresca da poda, produção por planta acumulada, comprimento, espessura, gemas floríferas e densidade florífera do ramo produtivo. Também foi avaliado de forma visual o ponto de enxertia. O porta-enxerto Umezeiro induziu menor vigor nos três locais de cultivo estudados e na média dos três anos. Ele pode ser indicado para utilização sob 'Maciel' nas condições edafoclimáticas do local 3. No local 1 o porta-enxerto, 'Nemaguard' possui alto vigor e maior produção acumulada, sendo o mais indicado. Já para o local 2, os porta-enxertos 'Capdeboscq', 'Okinawa' e 'Flordaguard' são os mais indicados. Os porta-enxertos afetam as características de crescimento e desenvolvimento das cultivares 'Chimarrita' e 'Maciel', o vigor destas é menor sobre o portaenxerto Umezeiro nos três locais de cultivo. Todos os portaenxertos podem ser indicados para os três locais de cultivo, com exceção do Umezeiro, que somente pode ser indicado em combinação com a cultivar 'Maciel' no local 3

Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study

BACKGROUND: The efficacy and effectiveness of nintedanib as a first-line therapy in idiopathic pulmonary fibrosis (IPF) patients have been demonstrated by clinical trials and real-life studies. Our aim was to examine the safety profile and effectiveness of nintedanib when it is utilized as a second-line treatment in subjects who have discontinued pirfenidone. METHODS: The medical charts of 12 patients who were switched from pirfenidone to nintedanib were examined retrospectively. The drug's safety was defined by the number of adverse events (AEs) that were reported; disease progression was evaluated based on the patient's vital status and changes in forced vital capacity (FVC) at 12-month follow-up. RESULTS: The numbers of patients experiencing AEs and of the AEs per patient in our study group didn't significantly differ with respect to a group of 56 individuals who were taking nintedanib as a first-line therapy during the study period (5/12 vs. 22/56; p = 0.9999, and 0.00 (0.00-1.00) vs. 0.00 (0.00-3.00); p = 0.517, respectively). Two out of the 3 patients who had been switched to nintedanib due to a rapid disease progression showed stabilized FVC values. CONCLUSIONS: Nintedanib was found to have an acceptable safety profile in the majority of the IPF patients switched from pirfenidone. Prospective studies are warranted to determine if the drug can effectively delay disease progression in these patients